IRWD: Ironwood Pharmaceuticals, Inc.
About
Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.
Current Value
$3.781 Year Return
Current Value
$3.781 Year Return
Key Details
Market Cap
$609.71M
P/E Ratio
-238.13
1Y Stock Return
-59.34%
1Y Revenue Growth
-12.48%
Dividend Yield
0.00%
Price to Book
-2.0
Strategies that include IRWD
Stock's related to IRWD
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DAVA | 44.15% | $1.16B | -59.28% | 0.00% |
| DLB | 37.51% | $6.76B | -16.58% | 1.69% |
| CDLX | 36.53% | $178.39M | -54.00% | 0.00% |
| EPAM | 34.52% | $12.91B | -11.78% | 0.00% |
| KELYA | 34.12% | $504.23M | -32.54% | 2.14% |
| ALTG | 33.85% | $236.78M | -29.08% | 3.22% |
| TWI | 33.69% | $424.30M | -48.58% | 0.00% |
| SUNS | 33.30% | $105.89M | +35.31% | 1.37% |
| ALLO | 33.03% | $444.50M | -24.82% | 0.00% |
| XEL | 32.91% | $41.42B | +15.91% | 3.12% |
| NARI | 32.32% | $2.98B | -11.66% | 0.00% |
| CC | 32.16% | $2.82B | -27.44% | 5.31% |
| BMBL | 31.83% | $845.98M | -43.90% | 0.00% |
| SVC | 31.40% | $431.62M | -63.31% | 23.74% |
| UGP | 31.23% | $3.51B | -35.98% | 3.88% |
| RAMP | 30.47% | $1.86B | -16.17% | 0.00% |
| ONL | 30.31% | $218.76M | -20.85% | 10.31% |
| MCB | 29.91% | $708.25M | +74.29% | 0.00% |
| RCKY | 29.88% | $155.86M | -17.74% | 2.95% |
| MBWM | 28.84% | $783.85M | +39.14% | 2.90% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| JLL | -0.01% | $12.26B | +68.32% | 0.00% |
| WELL | 0.01% | $86.04B | +55.71% | 1.86% |
| NOW | 0.02% | $210.55B | +52.92% | 0.00% |
| YALA | -0.02% | $587.51M | -23.43% | 0.00% |
| NXPI | -0.03% | $55.89B | +9.71% | 1.85% |
| GOOGL | -0.03% | $2.18T | +30.04% | 0.23% |
| CORZ | 0.05% | $4.60B | +3,201.26% | 0.00% |
| BK | -0.06% | $56.43B | +65.37% | 2.29% |
| AMKR | 0.07% | $6.26B | -6.38% | 1.25% |
| TAL | 0.08% | $4.54B | +2.16% | 0.00% |
| HDB | 0.09% | $160.88B | +7.31% | 1.10% |
| GOOG | -0.10% | $2.20T | +29.55% | 0.22% |
| CVE | -0.11% | $29.32B | -10.19% | 2.95% |
| MSTR | -0.12% | $87.25B | +773.24% | 0.00% |
| RMBS | -0.12% | $5.57B | -21.87% | 0.00% |
| HTHT | 0.12% | $11.34B | -0.47% | 0.00% |
| LRN | -0.12% | $4.43B | +74.97% | 0.00% |
| SFL | -0.14% | $1.55B | -4.05% | 9.77% |
| NBR | -0.14% | $694.91M | -21.77% | 0.00% |
| KFY | 0.14% | $3.93B | +48.94% | 1.86% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| KODK | -30.81% | $422.90M | +41.40% | 0.00% |
| STKL | -28.07% | $894.47M | +55.49% | 0.00% |
| PSTG | -25.85% | $16.35B | +36.41% | 0.00% |
| VERX | -25.20% | $7.99B | +89.70% | 0.00% |
| HRL | -23.20% | $16.30B | -8.38% | 3.81% |
| OKTA | -22.53% | $12.66B | +4.91% | 0.00% |
| XGN | -19.13% | $62.26M | +127.74% | 0.00% |
| HROW | -19.10% | $1.41B | +330.59% | 0.00% |
| NVMI | -18.57% | $5.16B | +44.02% | 0.00% |
| XPEL | -18.20% | $1.18B | -7.73% | 0.00% |
| KVYO | -16.22% | $9.29B | +24.95% | 0.00% |
| SPB | -16.20% | $2.53B | +37.09% | 1.89% |
| APP | -15.91% | $107.79B | +728.45% | 0.00% |
| CNQ | -15.50% | $71.04B | +1.89% | 6.81% |
| NRG | -14.61% | $19.22B | +109.87% | 1.71% |
| EQIX | -14.61% | $89.06B | +17.08% | 1.86% |
| EE | -14.30% | $747.78M | +68.74% | 0.33% |
| CELH | -13.89% | $6.41B | -47.81% | 0.00% |
| CPRX | -13.67% | $2.55B | +55.68% | 0.00% |
| CPNG | -13.57% | $43.51B | +49.69% | 0.00% |
ETF's related to IRWD
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 29.46% | $6.58B | 0.35% |
| XSLV | 28.49% | $322.27M | 0.25% |
| XPH | 28.44% | $157.87M | 0.35% |
| XSVM | 27.87% | $853.92M | 0.37% |
| RWJ | 27.53% | $1.75B | 0.39% |
| SMMV | 27.43% | $321.07M | 0.2% |
| PBE | 27.40% | $258.53M | 0.58% |
| IJS | 26.76% | $7.37B | 0.18% |
| RZV | 26.76% | $258.76M | 0.35% |
| REGL | 26.53% | $1.65B | 0.4% |
| FYX | 26.53% | $959.00M | 0.6% |
| EES | 26.43% | $668.71M | 0.38% |
| VIOV | 26.27% | $1.44B | 0.15% |
| CALF | 26.22% | $8.93B | 0.59% |
| BSVO | 26.17% | $1.53B | 0.47% |
| IWC | 26.15% | $933.99M | 0.6% |
| IWN | 26.13% | $13.17B | 0.24% |
| GSSC | 26.10% | $529.86M | 0.2% |
| GNOM | 26.07% | $70.59M | 0.5% |
| SLYV | 26.05% | $4.16B | 0.15% |
News
Yahoo
BOSTON, November 13, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024 at 7:30 a.m. GT at the Waldorf Hilton in London.
Yahoo
IRWD's third-quarter earnings miss estimates while revenues beat the same. The company maintains revenue guidance for 2024. Stock falls.
Yahoo
Despite a 19% revenue decline, Ironwood Pharmaceuticals Inc (IRWD) reports strong prescription demand growth and strategic advancements in its pipeline.
SeekingAlpha
The following slide deck was published by Ironwood Pharmaceuticals, Inc.
SeekingAlpha
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript November 7, 2024 8:30 AM ETCompany ParticipantsMatt Roache - Director of...
Yahoo
Ironwood (IRWD) delivered earnings and revenue surprises of -77.78% and 2.94%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.